Eric Sherbet

Lecturer

Bachelor’s in Commerce/Accounting, University of Virginia
JD, New York University School of Law

Biography

Eric Sherbet is executive vice president and general counsel for IQVIA. He is responsible for the company’s global legal operations, as well as compliance, privacy and external affairs.

Eric has more than 25 years of legal experience, of which more than 17 are in the global life science and technology industries. Prior to joining IQVIA in February 2018, he served as general counsel and secretary at Patheon, where he oversaw the company’s initial public offering and its $7.2 billion acquisition by Thermo Fisher.

Before that, Eric was general counsel and secretary at InVentiv Health, where he built the legal and compliance division into a global team. He also served as vice president, deputy general counsel and corporate secretary at Foster Wheeler AG and as vice president, corporate and securities law and corporate secretary at Avaya.

Eric earned his JD from the New York University School of Law and received his bachelor’s degree in commerce/accounting from the University of Virginia. Eric started his career as a CPA at KPMG.

Profile Types
Faculty, JD Program, Lecturers & Adjunct Professors, and Part-Time Faculty

View all profiles

Activities & Engagements

No upcoming activities or engagements.

Courses

LAW JD 928

Life as a Life Science General Counsel

2 credits

This is a 2-credit graded course for students who want to increase their understanding of the roles and responsibilities of a general counsel in the life sciences industry. The course will cover the substantive and/or doctrinal aspects of key areas of law in order to facilitate students' understanding of the general counsel's role in leading a company's legal function and advising key stakeholders, such as the board of directors and the CEO. The course will also orient students to the work environment in a large global enterprise and will cover the role of the general counsel in leading the company through the significant changes resulting from the new U.S. administration and the global response to those changes. Although the principles and concepts covered in this course will be generally applicable to most industries, the course will be taught through the lens of the life sciences industry. To facilitate discussion and dialogue, the class will be limited to 12 students. Planned guest speakers include a CEO and a member of the board of directors of a public company. Grading will be based on engagement (class participation and overall contributions to the classroom environment), a written memorandum to a "CEO" and an oral presentation to a "board of directors."

FALL 2026: LAW JD 928 A1, Aug 31st to Dec 3rd 2026
Days Start End Credits Instructors Bldg Room
Mon 6:30 pm 8:30 pm 2 Eric Sherbet